Examorelin
Examorelin, also known by its developmental code name EP-23905, is a synthetic peptide that acts as a growth hormone secretagogue (GHS). It is part of a class of drugs known as ghrelin mimetics, which mimic the action of the endogenous hormone ghrelin in the body. Ghrelin is often referred to as the "hunger hormone" because it stimulates appetite, but it also plays a significant role in the regulation of growth hormone (GH) secretion.
Mechanism of Action[edit | edit source]
Examorelin binds to and activates the Growth Hormone Secretagogue Receptor 1a (GHS-R1a), which is located in the pituitary gland and hypothalamus. This activation leads to an increase in the secretion of growth hormone by the pituitary gland. The increase in GH can contribute to the growth of lean body mass, improvement in lipid profile, and may enhance the healing of injuries.
Clinical Uses[edit | edit source]
While Examorelin has been extensively studied in clinical trials for its potential applications, it is not currently approved for medical use in any country. Research has focused on its potential for treating growth hormone deficiency in both children and adults, as well as its possible benefits in improving physical performance and body composition in athletes and the elderly.
Side Effects[edit | edit source]
As with other GH secretagogues, the use of Examorelin can lead to side effects similar to those of elevated GH levels, such as fluid retention, carpal tunnel syndrome, and increased blood sugar levels. However, the severity and incidence of these side effects can vary among individuals.
Research and Development[edit | edit source]
The development of Examorelin as a therapeutic agent has been part of the broader search for effective GH secretagogues that can serve as alternatives to direct GH administration, which is associated with several drawbacks, including the risk of developing antibodies against GH. Despite its promising profile, the development of Examorelin for clinical use has been limited, and it remains a compound of interest primarily in research settings.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
